05/15/2024
6:45 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:31 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
7:01 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:46 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
6:35 AM | Verrica Pharmaceuticals (Filer)
| Form DEFA14A | |
04/19/2024
6:40 AM | Verrica Pharmaceuticals (Filer)
| Form ARS | |
04/19/2024
6:30 AM | Verrica Pharmaceuticals (Filer)
| Form DEF 14A | |
|
03/19/2024
3:31 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:05 AM | Verrica Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:45 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:47 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:10 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
7:01 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:27 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
6:21 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:52 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:49 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:32 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:33 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:34 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:35 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
9:28 AM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144/A | |
11/15/2023
3:42 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
3:54 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
6:54 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
6:41 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
3:37 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:38 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:39 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:39 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:40 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
6:40 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:52 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023
5:47 PM | Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
6:31 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
8:02 AM | PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
8:03 AM | Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad) In January 2021, Donald Trump silently rolled out a special gift to the American public…
One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. |
06/12/2023
8:03 AM | Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
8:05 AM | Ballaron Craig (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
